Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research

Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research


Macular Degeneration Research
Completed Award

Photo Pending

Thomas A. Ferguson, Ph.D.

Washington University
St. Louis, MO, United States

Title: The Role of Autophagy in Age-related Eye Disease
Non-Technical Title: The Role of the Cell's Recycling System in the Development of Blinding Eye Diseases

Duration: July 1, 2011 - June 30, 2013
Award Type: Standard
Award Amount: $100,000


Autophagy (self-eating) is a recycling process for our cells that continuously clears damaged structures and recycles the ingredients to maintain proper cellular function. As we get older this recycling system does not work very well and this can leads to diseases of aging such as Alzheimer's and Age-related Macular Degeneration. Our studies will determine how important this process is for vision and if we can use this information to develop a new therapy to treat blinding eye disorders.


Retinal pigment epithelial (RPE) cells recycle waste and deliver nutrients to the light‐detecting cells in the retina. Excessive build‐up of waste products, called drusen, happens at the beginning of dry age‐related macular degeneration (AMD). Dr. Thomas Ferguson and colleagues will be investigating whether mice that have been made to have a faulty waste recycling process—called autophagy—develop the eye disease AMD. Eyes that can't recycle are likely to show signs of aging, sensitivity to light and develop blindness at an early age as a result of the loss of this recycling. These researchers have already made mice with problems in RPE autophagy to address their questions. They will track down the amount of recycling needed to keep eyes healthy and what protein or chemical “culprits” tip the balance to increase the risk of getting AMD. If a suitable target in the autophagy process is found, they will develop a new therapy to treat AMD.


Chan CC, Zhou Z, Green DR, Ferguson TA. Noncanonical autophagy promotes the visual cycle. Cell. 2013 Jul 18;154(2):365-76. doi: 10.1016/j.cell.2013.06.012. PubMed Icon Google Scholar Icon

Zhao H, Roychoudhury J, Doggett TA, Apte RS, Ferguson TA. Age-Dependent Changes in FasL (CD95L) Modulate Macrophage Function in a Model of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2013 Aug 7;54(8):5321-31. doi: 10.1167/iovs.13-12122. PubMed Icon Google Scholar Icon

Progress Updates:

Dr. Ferguson’s team is investigating what happens when autophagy (cell self-eating or recycling) is eliminated very early in the life in a very important cell type called the retinal pigment epithelial (RPE) cell. RPE cells are important for the health of our retina and when they cannot function properly, blindness develops. So far, the team has removed a gene from the RPE that is important for the recycling process. Studies over the first year of this award have shown that there are indeed signs of aging, including increased damage to the RPE, a rise in lipid (fat) content, elevated deposits beneath the RPE cells, and decreased vision. This suggests that this recycling pathway is very important in keeping the eye healthy so vision can be maintained. Dr. Ferguson’s experiments will help develop a new therapy that targets cellular recycling as a treatment for the blinding eye disorder AMD.